These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 27184483

  • 1. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J, Büttner-Herold M, Wach S, Wullich B, Hartmann A, Agaimy A.
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [Abstract] [Full Text] [Related]

  • 2. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 3. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT, Shi J, Liu H, Lin F.
    Am J Clin Pathol; 2012 Aug 30; 138(2):203-10. PubMed ID: 22904131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N, Cohen C, Siddiqui MT.
    Acta Cytol; 2014 Aug 30; 58(1):83-8. PubMed ID: 24281232
    [Abstract] [Full Text] [Related]

  • 6. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS, Shah SS, Torbenson MS, Wu TT.
    Hum Pathol; 2016 Sep 30; 55():11-6. PubMed ID: 27137985
    [Abstract] [Full Text] [Related]

  • 7. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
    Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, Al-Ahmadie H, Alves V, Xiao SY, Anders RA, Hart JA.
    Am J Surg Pathol; 2010 Aug 30; 34(8):1147-54. PubMed ID: 20661013
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J, Wei L.
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr 30; 43(4):246-50. PubMed ID: 24915815
    [Abstract] [Full Text] [Related]

  • 10. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
    Sang W, Zhang W, Cui W, Li X, Abulajiang G, Li Q.
    Tumour Biol; 2015 May 30; 36(5):3881-6. PubMed ID: 25577247
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M, Kwok S, Yano H, Pai RK.
    Cancer Cytopathol; 2012 Aug 25; 120(4):230-7. PubMed ID: 22434791
    [Abstract] [Full Text] [Related]

  • 13. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V.
    Hum Pathol; 2017 Nov 25; 69():90-95. PubMed ID: 28970136
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.
    Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S.
    Mod Pathol; 2013 Jun 25; 26(6):782-91. PubMed ID: 23348905
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
    Chen D, Li Z, Song Q, Qian L, Xie B, Zhu J.
    Medicine (Baltimore); 2018 Dec 25; 97(50):e13356. PubMed ID: 30557986
    [Abstract] [Full Text] [Related]

  • 16. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R, Nassar A, Cohen C, Siddiqui MT.
    Cancer Cytopathol; 2012 Aug 25; 120(4):223-9. PubMed ID: 22298472
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR, Abdel-Raouf SM.
    Pathol Oncol Res; 2015 Apr 25; 21(2):379-87. PubMed ID: 25108409
    [Abstract] [Full Text] [Related]

  • 18. Well differentiated arginase-1 negative hepatocellular carcinoma.
    Obiorah IE, Chahine J, Park BU, Ko K, deGuzman J, Kallakury B.
    Transl Gastroenterol Hepatol; 2019 Apr 25; 4():66. PubMed ID: 31620648
    [Abstract] [Full Text] [Related]

  • 19. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y.
    Am J Surg Pathol; 2016 May 25; 40(5):689-96. PubMed ID: 26735860
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Wang C, Shao X, Zhang X, Xie C, Yu J, Xu X, Yang J, Li Y, Xu W.
    Transl Cancer Res; 2020 Jan 25; 9(1):128-136. PubMed ID: 35117166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.